Targeting Hedgehog (Hh) Pathway for the Acute Myeloid Leukemia Treatment

被引：46

作者：

Terao, Toshiki ^{[1
,2
]}

Minami, Yosuke ^{[1
]}

机构：

[1] Natl Canc Ctr Hosp East, Dept Hematol, Kashiwa, Chiba 2778577, Japan

[2] Kameda Med Ctr, Dept Internal Med, Div Hematol Oncol, Kamogawa 2968602, Japan

来源：

CELLS | 2019年 / 8卷 / 04期

关键词：

Hedgehog pathway; acute myeloid leukemia; AML; leukemic stem cell; glioma; Smoothened; glasdegib; sonidegib; STEM-CELLS; MYELODYSPLASTIC SYNDROME; GLASDEGIB PF-04449913; CLINICAL-IMPLICATIONS; PHASE IB; GLI; INHIBITOR; MUTATIONS; ACTIVATION; THERAPY;

D O I：

10.3390/cells8040312

中图分类号：

Q2 [细胞生物学];

学科分类号：

071009 ; 090102 ;

摘要：

The Hedgehog (Hh) pathway, containing the Patched (PTCH) and Smoothened (SMO) multitransmembrane proteins, is the main regulator of vertebrate embryonic development. A non-canonical Hh pathway was recently observed in numerous types of solid cancers and hematological malignancies. Although acute myeloid leukemia (AML) is a common and lethal myeloid malignancy, the chemotherapy for AML has not changed in the last three decades. The Hh pathway and other intracellular signaling pathways are important for the tumor cells' cycle or therapeutic resistance of AML cells. In this article, we will review the current trends in Hh pathway inhibitors for treating AML.

引用

页数：11

共 50 条

[1] Targeting Hedgehog pathway in pediatric acute myeloid leukemia: challenges and opportunities
Pession, Andrea
Lonetti, Annalisa
Bertuccio, Salvatore
Locatelli, Franco
Masetti, Riccardo
EXPERT OPINION ON THERAPEUTIC TARGETS, 2019, 23 (02) : 87 - 91
[2] Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia
Shallis, Rory M.
Bewersdorf, Jan Philipp
Boddu, Prajwal C.
Zeidan, Amer M.
EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (08) : 717 - 729
[3] Hedgehog Pathway Inhibitors: A New Therapeutic Class for the Treatment of Acute Myeloid Leukemia
Jamieson, Catriona
Martinelli, Giovanni
Papayannidis, Cristina
Cortes, Jorge E.
BLOOD CANCER DISCOVERY, 2020, 1 (02): : 134 - 145
[4] Update on glasdegib in acute myeloid leukemia-broadening horizons of Hedgehog pathway inhibitors
Fersing, Cyril
Mathias, Fanny
ACTA PHARMACEUTICA, 2022, 72 (01) : 9 - 34
[5] Targeting of the Hedgehog pathway in myeloid malignancies: still a worthy chase?
Khan, Alesia A.
Harrison, Claire N.
McLornan, Donal P.
BRITISH JOURNAL OF HAEMATOLOGY, 2015, 170 (03) : 323 - 335
[6] Targeting mitochondrial respiration for the treatment of acute myeloid leukemia
Carter, Jenna L.
Hege, Katie
Kalpage, Hasini A.
Edwards, Holly
Huttemann, Maik
Taub, Jeffrey W.
Ge, Yubin
BIOCHEMICAL PHARMACOLOGY, 2020, 182
[7] Activation of hedgehog pathway in acute myeloid leukemia patients
Li, Zhe
Mao, Shudan
Jin, Jieping
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2017, 10 (08): : 8605 - 8609
[8] Rational for targeting the hedgehog signalling pathway in acute myeloid leukemia with FLT3 mutation
Bouscary, Didier
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4
[9] Novel therapies targeting the apoptosis pathway for the treatment of acute myeloid leukemia
Schimmer A.D.
Current Treatment Options in Oncology, 2007, 8 (4) : 277 - 286
[10] Glasdegib in the treatment of acute myeloid leukemia
Wolska-Washer, Anna
Robak, Tadeusz
FUTURE ONCOLOGY, 2019, 15 (28) : 3219 - 3232

← 1 2 3 4 5 →